More than 80 million people in Europe are affected, and many more are undiagnosed, with primary care practitioners ill-prepared to identify the conditions.

Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.

People with one of more than 20 breathing conditions could be eligible for up to £749 a month from the Department for Work ...

Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.

Plenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...

Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...

Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP) ...

The following is a summary of “Triple overlap of COPD, severe obesity, and high risk of OSA: insights from an NHANES analysis ...

New Partnership with Leonard Nimoy’s Daughter Aims to Raise COPD Awareness ...

Short-course fluoroquinolone treatment is as effective as the conventional 7-day course for acute exacerbations of chronic ...

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as ...